What Is "GLP-3"? The Truth Behind This Trending Term

Direct Answer

No, "GLP-3" is not a real human hormone, and there is no FDA-recognized drug class by that name. The human body produces GLP-1 and GLP-2, both real, well-studied hormones, but not a third. "GLP-3" is an informal nickname that emerged in media coverage and online discussion for retatrutide, an investigational triple-agonist medication developed by Eli Lilly that activates three separate hormone receptors, GLP-1, GIP, and glucagon, at once. The "3" refers to the number of receptor targets, not a newly discovered hormone.

Where the Nickname Actually Came From

The logic is straightforward, if informal: semaglutide became known as a "GLP-1" drug, tirzepatide, which targets two receptors, is sometimes called a "dual agonist," and retatrutide, which targets three, got nicknamed "GLP-3" by extension. It's a tidy shorthand, but it's not the accurate scientific term. The correct term, used by Eli Lilly, the FDA, and peer-reviewed research, is triple hormone receptor agonist or triple agonist.

What Retatrutide Actually Is

Retatrutide is a real, genuinely significant investigational medication, currently in Phase 3 clinical trials under Eli Lilly's TRIUMPH program, covered in full detail on our Retatrutide medication page and TRIUMPH trials page. It is not FDA-approved and not available by prescription as of this writing, though Phase 3 results have shown substantial average weight loss, among the strongest reported for any obesity medication in development.

A Real Warning Worth Knowing

Because "GLP-3" sounds like an official, next-generation drug category, some online sellers and unregulated "research peptide" vendors use the term specifically to make unapproved products sound more legitimate than they are. Products marketed as "GLP-3 peptide" online are not verified to contain retatrutide, or anything at all matching the real investigational drug. This is the same pattern covered in detail on our Reta Peptide safety warning, unregulated products sold under research-chemical framing, often with unverified purity and no legitimate path to human use outside clinical trial enrollment.

Is There a GLP-2?

Yes, genuinely, unlike "GLP-3." GLP-2 is a real, distinct hormone, primarily studied for its role in intestinal health rather than blood sugar or weight management, and it isn't related to the GLP-1 medications covered throughout this library.

Bottom Line

If you're seeing "GLP-3" used to describe a medication, it almost always means retatrutide specifically, a real, promising, but still investigational drug, not a new hormone class or an approved treatment available today.

References

• Coskun T, et al. LY3437943, A Novel Triple GIP, GLP-1, and Glucagon Receptor Agonist. Cell Metabolism (2022)
• Fox News: 'GLP-3' Retatrutide Drug Delivers Major Weight Loss Breakthrough in Trials
• The RX Index: What Is GLP-3? Retatrutide and FDA Status (2026)

Related Resources

• Retatrutide Medication Guide
• The TRIUMPH Trials
• What Is "Reta Peptide," and Is It Safe to Buy Online?

Related Articles

• Semaglutide vs. Tirzepatide

Explore More

Explore the full GLP-1 Tracker knowledge base on DietApp.com

Get Started

Explore the GLP-1 Tracker knowledge base for accurate, sourced information on every GLP-1 and investigational medication, including retatrutide.

About DietApp.com

DietApp.com combines evidence-based GLP-1 medication education with practical treatment tracking tools. This article is for general informational purposes and is not medical advice.